5-substituted isoindoline compounds
Details for Australian Patent Application No. 2009251815 (hide)
International Classifications
Event Publications
6 January 2011 PCT application entered the National Phase
PCT publication WO2009/145899 Priority application(s): WO2009/145899
20 January 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Celgene Corporation; Ehab Khalil, Application No. 2009251815, under INID (71) remove co-applicant Khalil, Ehab
17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009251816-Methods and compositions for sleep disorders and other disorders
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser